{"id":295696,"date":"2019-10-02T22:48:21","date_gmt":"2019-10-03T05:48:21","guid":{"rendered":"https:\/\/nai500.com\/?p=295696"},"modified":"2019-10-02T22:48:21","modified_gmt":"2019-10-03T05:48:21","slug":"%e4%b8%ad%e5%9b%bd%e6%81%92%e6%b6%a6%e8%be%be%e7%94%9f%e5%ae%8c%e6%88%90b%e8%bd%ae%e8%9e%8d%e8%b5%84","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2019\/10\/%e4%b8%ad%e5%9b%bd%e6%81%92%e6%b6%a6%e8%be%be%e7%94%9f%e5%ae%8c%e6%88%90b%e8%bd%ae%e8%9e%8d%e8%b5%84\/","title":{"rendered":"\u4e2d\u56fd\u6052\u6da6\u8fbe\u751f\u5b8c\u6210B\u8f6e\u878d\u8d44"},"content":{"rendered":"<p>\u4e0a\u6d77\u6052\u6da6\u8fbe\u751f\u751f\u7269\u79d1\u6280\u6709\u9650\u516c\u53f8\u5b8c\u6210B\u8f6e$2800\u4e07\u878d\u8d44\uff0c\u672c\u8f6e\u878d\u8d44\u7531\u6df1\u521b\u6295\u9886\u6295\u3002\u6052\u6da6\u8fbe\u751f\u4f4d\u4e8e\u4e0a\u6d77\u7684\u5f20\u6c5f\u9ad8\u79d1\u6280\u56ed\u533a\u3002\u8be5\u516c\u53f8\u4e8e2015\u5e74\u6210\u7acb\uff0c\u62e5\u6709\u201c\u4e00\u4e2a\u4e2d\u5fc3\u548c\u591a\u4e2a\u4eae\u70b9\u201d\u3002\u6052\u6da6\u8fbe\u751f\u7684\u4e3b\u8981\u91cd\u70b9\u662fCAR-T\u4ea7\u54c1\uff0c\u4f46\u5b83\u4e5f\u5728\u5f00\u53d1\u4f7f\u7528CAR-Natural Killer Cells\uff08\u57fa\u4e8e\u6811\u7a81\u7ec6\u80de\u7684\u764c\u75c7\u75ab\u82d7\uff09\u7684\u5176\u4ed6\u4ea7\u54c1\u3002\u6052\u6da6\u8fbe\u751f\u5df2\u5f00\u59cb\u5bf9\u5176\u4e24\u79cdCAR-T\u7597\u6cd5\u8fdb\u884c\u4e2d\u56fd\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n<p>\u82f1\u6587\u6765\u6e90\uff1aChina Biotoday<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shanghai Hrain Biotechnology, a clinical-stage oncology immunotherapy company, raised $28 million in a Series B round led by Shenzhen Capital. Hrain is located in Shanghai&#8217;s Zhangjiang Hi-Tech Park. Founded in 2015 by returnees, the company has &#8220;one center and multiple highlights.&#8221; Its major emphasis is CAR-T products, but it also is developing other products using CAR-Natural Killer Cells, dendritic cell-based cancer vaccines. and invariant natural killer T cells. Hrain has started China clinical trials for two of its CAR-T therapies. <\/p>\n","protected":false},"author":9,"featured_media":295693,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[459],"class_list":["post-295696","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-459","sectors-life-science-zh-hans","locations-china-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/295696","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=295696"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/295696\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/295693"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=295696"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=295696"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=295696"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}